Acne

Therapeutics Clinical Research has a research study to evaluate the efficacy and safety of a novel investigational medication for patients with moderate to severe acne. 

Inclusion Criteria

• Males and females age 18 years and older
• Clinical diagnosis of moderate to severe acne
• Acne which has been unresponsive to oral antibiotics

Exclusion Criteria

• Use of certain medications or treatments (to be discussed)
• Recent history of drug or alcohol abuse
• Skin diseases that may interfere with evaluation
• Pregnant, planning a pregnancy or nursing

Click here to see if you prequalify: https://www.research.net/s/TherapeuticsResearchAcne

Thinning Hair

Therapeutics Clinical Research is conducting a medical research study of an investigational product for thinning hair.

Inclusion Criteria

• Adult women, age 18 to 59
• Adult men, age 18 to 49
• General good health
• Have hair loss
• Willing to maintain the same hairstyle, color and hair regimen throughout the study

Exclusion Criteria

• Pregnant, planning a pregnancy or breastfeeding women
• Abnormalities of the scalp
• Underlying medical problems such as HIV, uncontrolled systemic disease, uncontrolled hyper- or hypothyroidism
• Hair transplants or scalp reductions
• Use of hair weaves, extensions or wigs within 3 months prior to study entry

 

New Topical Medication for Rosacea

Therapeutics Clinical Research is doing research to evaluate the effectiveness and safety of a new investigational topical medication for patients with moderate to severe rosacea. 

Inclusion Criteria:

• Males and females age 18 years and older
• Moderate to severe papulopustular rosacea

Exclusion Criteria:

• Other forms of rosacea or facial dermatoses that may be confounded with papulopustular rosacea
• Underlying known disease or surgical/medical condition
• Clinically significant abnormal lab values
• A beard that would interfere with study treatment and assessment
• Female who is breast feeding, pregnant, or planning to become pregnant

Rosacea Study

Therapeutics Clinical Research is conducting a medical research study of an investigational drug for adults with facial bumps caused by rosacea.

Inclusion Criteria:

• Adults 18 and older
• General good health
• 5-40 papules on the face caused by papulopustular rosacea

Exclusion Criteria:

• Pregnant, planning a pregnancy or breastfeeding women
• Topical or oral use of dapsone
• Current use of niacin > 500mg/day
• Use of light of laser therapy within 3 months
• Ocular rosacea
• Use of tanning beds or other intense UV exposure during the study (mountain sports, sunbathing, etc.)
• Participation in another investigational drug trial within 30 days